Gujarat Terce Laboratories Q3 FY24 Results: Revenue Increased by 9.37% YoY & Profit at ₹0.67Cr
Gujarat Terce Laboratories Q3 FY24 results: Revenue increased by 9.37% YoY & profit at ₹0.67Cr
Gujarat Terce Laboratories declared their Q3 FY24 results on 05 Feb, 2024, with the topline increasing by 9.37% and the profit coming at ₹0.67Cr.
It is noteworthy that Gujarat Terce Laboratories had declared a loss of ₹0Cr in the previous fiscal year's same period.
In comparison to the previous quarter, the revenue grew by 8.23%.
The operating income was up by 67.63% quarter-over-quarter and increased by 1354.23% year-over-year.
The EPS for Q3 FY24 is ₹0.91, which increased by 24237.93% year-over-year.
Gujarat Terce Laboratories has delivered -4.98% return in the last 1 week, 24.66% return in the last 6 months, and 5.05% YTD return.
Currently, Gujarat Terce Laboratories has a market cap of ₹22.21Cr and a 52-week high/low of ₹37.3 and ₹14.8 respectively.
Gujarat Terce Laboratories Financials
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 13.02 | 12.03 | +8.23% | 11.9 | +9.37% |
| Depreciation/ Amortization | 0.09 | 0.09 | -0.11% | 0.07 | +32.22% |
| Total Operating Expense | 12.26 | 11.58 | +5.91% | 11.85 | +3.47% |
| Operating Income | 0.76 | 0.45 | +67.63% | 0.05 | +1354.23% |
| Net Income Before Taxes | 0.67 | 0.33 | +101.02% | -0 | +24128.57% |
| Net Income | 0.67 | 0.33 | +101.02% | -0 | +24128.57% |
| Diluted Normalized EPS | 0.91 | 0.45 | +102.22% | -0 | +24237.93% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.